US Stock MarketDetailed Quotes

DNTH Dianthus Therapeutics

Watchlist
  • 24.490
  • +0.360+1.49%
Close Feb 14 16:00 ET
  • 24.490
  • 0.0000.00%
Post 16:00 ET
724.83MMarket Cap-10.72P/E (TTM)

About Dianthus Therapeutics Company

Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company. It designs and delivers novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company was founded on June 17, 2015 and is headquartered in New York, NY.

Company Profile

SymbolDNTH
Company NameDianthus Therapeutics
Listing DateJun 21, 2018
Founded2015
CEOMr. Marino Garcia
MarketNASDAQ
Employees53
Fiscal Year Ends12-31
Address7 Times Square,43rd Floor
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10036
Phone1-929-999-4055
Websitehttp://dianthustx.com

Company Executives

  • Name
  • Position
  • Salary
  • Marino Garcia
  • President, Chief Executive Officer and Director
  • --
  • Edward G. Carr
  • Chief Accounting Officer
  • --
  • Ryan Savitz
  • Chief Financial Officer, Chief Business Officer and Treasurer
  • --
  • Dr. Simrat Randhawa, M.D.
  • Chief Medical Officer
  • --
  • Adam M. Veness
  • Senior Vice President, General Counsel and Secretary
  • --
  • Leon O. Moulder, Jr
  • Chairman of the Board
  • --
  • Dr. Steven Joseph Romano, M.D.
  • Director
  • --
  • Dr. Jonathan Violin, M.B.A.,PhD
  • Director
  • --
  • Anne M. McGeorge
  • Independent Director
  • --
  • Alison F. Lawton
  • Independent Director
  • --
  • Tomas Kiselak
  • Independent Director
  • --
  • Paula Soteropoulos
  • Independent Director
  • --

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
PILOT
831175
+30.00%
XINGANJIANG
873167
+29.99%
Beijing Highlander Digital Technology
300065
+20.05%
4
Hangzhou Gaoxin Materials Technology
300478
+20.02%
5
Shijihengtong Technology
301428
+20.01%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Trump's comeback to the Office
Following Trump's Policies to Seek Investment Opportunities
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
MicroStrategy Q4 2024 earnings conference call